| 引用本文：邵蓉,颜建周.专利药品进入基本药物目录的意义与挑战[J].中国卫生政策研究,2012,5(7):31-34 |
|
| 专利药品进入基本药物目录的意义与挑战 |
| 投稿时间：2012-06-19 修订日期：2012-06-22 PDF全文浏览 HTML全文浏览 |
| 邵蓉1, 颜建周1 |
| 中国药科大学医药产业发展研究中心 |
| 摘要:本文分析了专利药品进入基本药物目录在提高居民用药层次、保证药品可及性方面的积极意义以及该做法在支付能力和专利时效性方面所面临的挑战。建议在政府财政和医保基金的可承受范围内，通过价格谈判机制和基本药物目录的动态调节机制来降低专利药品价格，并使专利药品进入基本药物目录变为常态，成为我国基本药物目录动态管理的一部分。 |
| 关键词:基本药物目录 动态管理 专利药品 价格谈判 |
|
| Research on the significance and challenges of patent medicines in the essential medicines list formula |
|
|
| Abstract:The paper analyses the significance of patent medicines being listed into the essential medicine list, in terms of improving residents’ medication level and the access to medicine，as well as its challenges on the affordability and timeliness of patent medicines.In this paper, we suggest that a negotiation mechanism should be established and be dynamically adjusted to decease the price of patient medicine within financing ability and the affordable insurance funds. In other words, this enables to make it a normal condition to get the patient medicine integrated into the essential medicine list. In turn, it could dynamically administer the essential medicine list in China. |
| Key words:Essential medicine list Dynamic administration Patent medicine Price negotiation |
| 摘要点击次数: 2786 全文下载次数: 4883 |
|
|
